Journal article

ANTITUMOR ACTIVITY OF PEMBROLIZUMAB PLUS DINACICLIB IN PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA: THE PHASE 1B KEYNOTE-155 STUDY

G Gregory, P Walker, D Mahadevan, D Wang, J Chang, F Hernandez-Ilizaliturri, A Klein, W Rybka, N Wagner-Johnston, C Escobar, JM Pagel, A Mohrbacher, S Opat, J Shortt, H Ma, J Gwo, M Farooqui, H Quach

Hematological Oncology | Wiley | Published : 2019

University of Melbourne Researchers

Citation metrics